Close

Analyst Ratings for Theseus Pharmaceuticals Inc. (thrx)

thrx Rating Summary

thrx Price Target Summary

* Over Last 12-Mos
  |   Expand Research on thrx
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $42.00 (+934.5%) * Over Last 12-Mos
Rating Score: 4.6 / 10   Percentile Rank: 47%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
7/14/2023 Needham Ami Fadia Downgrade Hold
(Buy)
N/A
(N/A)
9.52
(4.06)
-57.35% Details
3/16/2023 Stifel
» Updated 5/23/2023
Bradley Canino New Coverage Buy
(N/A)
110.00
(105.00)
7.81
(4.06)
-48.02% Details